May 2020

Adelaide, Australia, 25 May 2020 – GPN Vaccines is pleased to announce Dr Ismail Kola has joined the Company’s Board of Directors. Dr Kola is a Senior Partner at Forepont Capital, a New York-based venture capital firm investing in pharmaceutical and biotechnology companies that improve healthcare outcomes....

Protecting children and adults from the world’s foremost bacterial pathogen